SOLVNYSE
Solventum Corporation
$0.00
0.000.00%
15-min delay
E
Open—
Prev Close—
Market Cap$14.62B
P/E (TTM)10.49
EPS$6.11
Earnings2026-11-05
DAY RANGE
$0.00$0.00

Solventum Corporation is a healthcare company that develops, manufactures, and commercializes solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. It operates through three primary segments: MedSurg, which provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, delivering software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. The company serves markets in the United States, where it generates the majority of its revenue, and internationally, focusing on medical instruments and supplies within the healthcare sector. Founded in 2023 and headquartered in Eagan, Minnesota, Solventum Corporation plays a key role in advancing healthcare innovations for medical professionals and patients.

SectorHealth Services
Employees20584
ISINUS83444M1018
Address1750 Yankee Doodle Road Building 275-6W-20 2510 Conway Avenue East St. Paul, Eagan, MN, 55121
Key Statistics
Full Stats
Market Cap$14.62B
Enterprise Value$19.49B
P/E Ratio (TTM)10.49
P/S Ratio1.82
P/B Ratio3.04
Forward P/E10.27
EPS (TTM)$8.18
EPS (FY)$6.11
Revenue (TTM)$8.31B
Profit Margin17.26%
Operating Margin8.48%
ROE38.86%
Debt/Equity1.10
Avg Vol (30d)846K
Beta (1Y)0.46
Beta (3Y)0.70
Beta (5Y)0.70
Shares Out170.22M
Float144.58M
Dividend—
Next Earnings2026-11-05
Short Interest—
52-Week Range
$0.00
$62.38$94.16
Upgrades / Downgrades
Upgrades0
Maintained0
Downgrades0
Grades Consensus
Price Target Consensus
—
High
—
Low
—
Median
—
Current
—
Forward Estimates

Seasonality

Full seasonality